Characterization of Infliximab and Biosimilar Use in a Community Health System

Authors

Abigail Geyer PharmD, Parkview HealthFollow
Luke Keller PharmD, BCPS, BCCCP, Parkview HealthFollow
Curtis Stump PharmD, Parkview HealthFollow
Renu Johnson PharmD, BCPS, Parkview HealthFollow

Abstract

2021 ASHP Midyear Clinical Meeting / Virtual / Poster #1129769

Objective: To identify characteristics of infliximab and relevant biosimilar use within a community health system.

Document Type

Article

Publication Date

2021

Recommended Citation

Geyer, Abigail PharmD; Keller, Luke PharmD, BCPS, BCCCP; Stump, Curtis PharmD; and Johnson, Renu PharmD, BCPS, "Characterization of Infliximab and Biosimilar Use in a Community Health System" (2021). Parkview Pharmacy Department. 56.
https://researchrepository.parkviewhealth.org/pharma/56